BioCentury | Mar 16, 2021
Product Development

The clinical pipeline for Alzheimer’s disease: Data Byte

...PQ912) Semorinemab, RG6100 ABBV-8E12, C2N-8E12 gosuranemab, BIIB092, bms-986168, ipn007 zagotenemab, LY3303560 AL003 AL002 AR1001 BPN14770 AMX0035 Simufilam, sumifilam (PTI-125) Eli Lilly and Co. Eisai Co. Ltd. Biogen Inc. Alzheon Inc. Annovis...
BioCentury | Dec 30, 2020
Product Development

2020’s silver linings, New Year’s hopes: a BioCentury podcast

...Square Orchestra recently presented a benefit concert, Symphony...
BioCentury | Dec 15, 2020
Product Development

Vaccines march forward & CAR Ts move earlier: a BioCentury podcast

...give a shout out to our friends at Kendall Square Orchestra they will be presenting Symphony...
BioCentury | Dec 8, 2020
Product Development

ASH Monday, Biden’s picks & vaccine conundrums: a BioCentury podcast

...Kendall Square Orchestra they will be presenting symphony...
BioCentury | Dec 1, 2020
Product Development

Moderna moves & Immunocore breaks through: a BioCentury podcast

...Kendall Square Orchestra who kindly do our intro and outro music. They will be presenting Symphony...
...inspire through music while supporting causes related to healthcare and education, such as their upcoming Symphony...
BioCentury | Jun 6, 2020
Finance

Daily Chart: NASDAQ’s dazzling debuts

...Biopharma Lyra Therapeutics Inc. Applied Molecular Transport Inc. Arcutis Biotherapeutics Inc. Beam Therapeutics Inc. ORIC Pharmaceuticals Inc. PPD Inc. Schrödinger Inc. Zentalis Pharmaceuticals Inc. Annovis...
BioCentury | Apr 3, 2020
Deals

Servier adds mAb platform via takeout of former European biotech darling Symphogen

...series E round, which at the time was the largest European venture round ever (see “Symphony...
BioCentury | Feb 15, 2020
Management Tracks

Immunomedics names Itri CMO; plus Hua, GenMark, AAM, Vividion, Sophia Genetics, Enterprise, Encoded, Palleon and more

...efficiently generate real-world data, hired Neal Bibeau as CEO. He was president and CEO of Symphony...
BioCentury | Jan 30, 2020
Financial News

Jan. 29 Financial Quick Takes: Black Diamond prices upsized IPO; plus Biohaven, Denali, Concert follow-ons, Lyra, Annovis, Histogen-Conatus and CellFE

...months of therapy to sinonasal passages. First-day pop for microcap Annovis Shares of neurodegeneration company Annovis...
...rose $3.59 (69%) to close at $9.59 after the biotech priced its IPO at $6. Annovis...
...Associate Editor and Elizabeth S. Eaton, Staff Writer Biohaven Pharmaceutical Holding Co. Ltd. Denali Therapeutics Inc. Concert Pharmaceuticals Inc. Annovis...
BioCentury | Oct 4, 2019
Finance

Biotechs likely to flood IPO market ahead of 2020 election

...Up to $23 Dev (device) Jiangsu Jibeier Pharmaceutical Co. Ltd. (Shanghai) 7/3/19 $100.2 Mkt (drug) Annovis...
Items per page:
1 - 10 of 265
BioCentury | Mar 16, 2021
Product Development

The clinical pipeline for Alzheimer’s disease: Data Byte

...PQ912) Semorinemab, RG6100 ABBV-8E12, C2N-8E12 gosuranemab, BIIB092, bms-986168, ipn007 zagotenemab, LY3303560 AL003 AL002 AR1001 BPN14770 AMX0035 Simufilam, sumifilam (PTI-125) Eli Lilly and Co. Eisai Co. Ltd. Biogen Inc. Alzheon Inc. Annovis...
BioCentury | Dec 30, 2020
Product Development

2020’s silver linings, New Year’s hopes: a BioCentury podcast

...Square Orchestra recently presented a benefit concert, Symphony...
BioCentury | Dec 15, 2020
Product Development

Vaccines march forward & CAR Ts move earlier: a BioCentury podcast

...give a shout out to our friends at Kendall Square Orchestra they will be presenting Symphony...
BioCentury | Dec 8, 2020
Product Development

ASH Monday, Biden’s picks & vaccine conundrums: a BioCentury podcast

...Kendall Square Orchestra they will be presenting symphony...
BioCentury | Dec 1, 2020
Product Development

Moderna moves & Immunocore breaks through: a BioCentury podcast

...Kendall Square Orchestra who kindly do our intro and outro music. They will be presenting Symphony...
...inspire through music while supporting causes related to healthcare and education, such as their upcoming Symphony...
BioCentury | Jun 6, 2020
Finance

Daily Chart: NASDAQ’s dazzling debuts

...Biopharma Lyra Therapeutics Inc. Applied Molecular Transport Inc. Arcutis Biotherapeutics Inc. Beam Therapeutics Inc. ORIC Pharmaceuticals Inc. PPD Inc. Schrödinger Inc. Zentalis Pharmaceuticals Inc. Annovis...
BioCentury | Apr 3, 2020
Deals

Servier adds mAb platform via takeout of former European biotech darling Symphogen

...series E round, which at the time was the largest European venture round ever (see “Symphony...
BioCentury | Feb 15, 2020
Management Tracks

Immunomedics names Itri CMO; plus Hua, GenMark, AAM, Vividion, Sophia Genetics, Enterprise, Encoded, Palleon and more

...efficiently generate real-world data, hired Neal Bibeau as CEO. He was president and CEO of Symphony...
BioCentury | Jan 30, 2020
Financial News

Jan. 29 Financial Quick Takes: Black Diamond prices upsized IPO; plus Biohaven, Denali, Concert follow-ons, Lyra, Annovis, Histogen-Conatus and CellFE

...months of therapy to sinonasal passages. First-day pop for microcap Annovis Shares of neurodegeneration company Annovis...
...rose $3.59 (69%) to close at $9.59 after the biotech priced its IPO at $6. Annovis...
...Associate Editor and Elizabeth S. Eaton, Staff Writer Biohaven Pharmaceutical Holding Co. Ltd. Denali Therapeutics Inc. Concert Pharmaceuticals Inc. Annovis...
BioCentury | Oct 4, 2019
Finance

Biotechs likely to flood IPO market ahead of 2020 election

...Up to $23 Dev (device) Jiangsu Jibeier Pharmaceutical Co. Ltd. (Shanghai) 7/3/19 $100.2 Mkt (drug) Annovis...
Items per page:
1 - 10 of 265